MedSci Healthcare (HKG:2415) expects an attributable profit of not less than 10 million yuan for the first half, compared with 200,000 yuan a year earlier, according to a Wednesday Hong Kong bourse filing.
Shares of the online physician platform lost nearly 4% in Thursday's late afternoon trade.
The company said the surge was driven by stronger demand for precision omni-channel marketing in China's pharmaceutical sector, improved production efficiency through artificial intelligence, and tighter cost controls under its ESG initiatives.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.